We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+14.21%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$987M
AUM Growth
+$120M
(+14%)
Cap. Flow
+$63.5M
Cap. Flow
% of AUM
6.44%
Top 10 Holdings %
Top 10 Hldgs %
5.22%
Holding
1,870
New
579
Increased
363
Reduced
419
Closed
480
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$6.71M |
| 2 |
DexCom
DXCM
|
+$6.59M |
| 3 |
X
US Steel
X
|
+$6.1M |
| 4 |
CMBT
CMB.TECH NV
CMBT
|
+$5.09M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$4.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GOOS
Canada Goose Holdings
GOOS
|
+$21.9M |
| 2 |
Constellation Brands
STZ
|
+$9.52M |
| 3 |
Lumen
LUMN
|
+$7.13M |
| 4 |
Weyerhaeuser
WY
|
+$6.3M |
| 5 |
FedEx
FDX
|
+$6.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.75% |
| 2 | Technology | 15.19% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Industrials | 12.06% |
| 5 | Financials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
John Wiley & Sons Class A
WLY
$2.66B
| $260K | 0.03% |
5,888
-9,225
| -61% | -$452K |
|
1077
Worthington Enterprises
WOR
$2.86B
| $260K | 0.03% |
+11,289
| New | +$259K |
|
1078
Flex
FLEX
$44.8B
| $258K | 0.03% |
34,246
+4,075
| +14% | +$29.2K |
|
1079
Lee Enterprises
LEE
$182M
| $258K | 0.03% |
7,811
+130
| +2% | +$3.71K |
|
1080
Nu Skin
NUS
$267M
| $258K | 0.03% |
5,396
-24,629
| -82% | -$1.49M |
|
1081
Applied Materials
AMAT
$428B
| $257K | 0.03% |
+6,484
| New | +$246K |
|
1082
Affiliated Managers Group
AMG
$9.76B
| $257K | 0.03% |
+2,398
| New | +$255K |
|
1083
Group 1 Automotive
GPI
$3.18B
| $257K | 0.03% |
3,968
-4,418
| -53% | -$268K |
|
|
SMAR
1084
DELISTED
Smartsheet Inc.
SMAR
| $256K | 0.03% |
+6,274
| New | +$217K |
|
1085
Arrow Electronics
ARW
$10.4B
| $255K | 0.03% |
+3,304
| New | +$254K |
|
1086
CorVel
CRVL
$3.19B
| $255K | 0.03% |
+11,733
| New | +$251K |
|
1087
Neogen
NEOG
$2.5B
| $255K | 0.03% |
8,872
-1,984
| -18% | -$60K |
|
1088
Marriott Vacations Worldwide
VAC
$4.24B
| $255K | 0.03% |
+2,725
| New | +$245K |
|
1089
McGrath RentCorp
MGRC
$2.92B
| $254K | 0.03% |
4,492
+563
| +14% | +$30.1K |
|
|
PETQ
1090
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $254K | 0.03% |
8,100
-23,800
| -75% | -$672K |
|
|
BPT
1091
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $253K | 0.03% |
9,500
-1,100
| -10% | -$27.7K |
|
|
B
1092
Barrick Mining
B
$73.2B
| $253K | 0.03% |
+18,447
| New | +$238K |
|
1093
Vale
VALE
$62.6B
| $253K | 0.03% |
+19,372
| New | +$251K |
|
|
TBRG
1094
DELISTED
TruBridge
TBRG
| $253K | 0.03% |
8,512
-1,288
| -13% | -$37.2K |
|
|
BERY
1095
DELISTED
Berry Global Group, Inc.
BERY
| $253K | 0.03% |
5,106
-1,824
| -26% | -$86.5K |
|
|
MNDT
1096
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $253K | 0.03% |
15,051
-1,825
| -11% | -$30.7K |
|
|
ACR
1097
ACRES Commercial Realty
ACR
$108M
| $252K | 0.03% |
7,916
-6,408
| -45% | -$204K |
|
1098
Astronics
ATRO
$3.84B
| $252K | 0.03% |
+9,258
| New | +$247K |
|
1099
Brown & Brown
BRO
$23.9B
| $252K | 0.03% |
+8,535
| New | +$244K |
|
1100
Nokia
NOK
$52.3B
| $252K | 0.03% |
+44,052
| New | +$270K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2019 Portfolio in Review
As of Q1 2019, GSA Capital Partners held 1,870 positions worth $987M, up 14% from $867M the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
GSA Capital Partners deployed $63.5M of net new capital in Q1 2019, opening 579 new positions and adding to 363 existing holdings. Its largest new stake was DexCom: 187,420 shares worth $5.58M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Lumen, an estimated $7.13M trimmed.
- GSA Capital Partners's largest Q1 2019 buy was DexCom: 187,420 shares worth $5.58M.
- GSA Capital Partners added most to Biogen in Q1 2019, an estimated $6.71M increase.
- GSA Capital Partners's biggest Q1 2019 reduction was Lumen, cutting an estimated $7.13M.
- GSA Capital Partners fully exited Canada Goose Holdings in Q1 2019, selling an estimated $21.9M.
- GSA Capital Partners's ten largest holdings make up 5.2% of its $987M portfolio in Q1 2019.
- GSA Capital Partners opened 579 new positions and closed 480 in Q1 2019.
- GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $987M.
Based on GSA Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.